NET PROFIT (x1000 EUR)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
1,373
|
16,829
|
-923 |
| Total assets |
1,662,397
|
1,063,813
|
1,078,562 |
| Current assets |
5,147
|
4,699
|
19,444 |
| Current liabilities |
10,311
|
9,366
|
69,344 |
| Equity capital |
1,652,086
|
1,054,447
|
1,009,217 |
| - share capital |
67
|
68
|
68 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
99.4%
|
99.1%
|
93.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
49.9%
|
50.2%
|
28.0% |
| Return on equity (ROE) |
0.1%
|
1.6%
|
-0.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.